Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae
Not Applicable
Terminated
- Conditions
- Crohn's Disease
- Registration Number
- NCT01012726
- Lead Sponsor
- Gerhard Rogler
- Brief Summary
The investigators will study whether local instillation of Doxycycline and Acetylcystein results in fistula closure in CD patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Fistula closure 01.08.2009 - 31.07.2012
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie doxycycline and acetylcystein's effect on CD-associated fistulae?
How does the combination of doxycycline and acetylcystein compare to standard-of-care treatments for Crohn's disease fistulae?
Are there specific biomarkers that predict response to doxycycline and acetylcystein in fistulizing Crohn's disease?
What are the potential adverse events associated with local instillation of doxycycline and acetylcystein in CD patients?
What other compounds or combination therapies are being explored for CD-associated fistulae alongside doxycycline and acetylcystein?